Could We Actually Cure Arthritis? Three New Approaches That Have Me Paying Attention

Every week in clinic, I sit across from patients with bone-on-bone knee arthritis and have some version of the same conversation: we can manage your pain, we can modify your activity, and when you're ready, we can replace the joint. What I can't do — yet — is regrow the cartilage you've lost. That's been the fundamental limitation of osteoarthritis treatment for my entire career.

That may be changing. ARPA-H, a federal research agency modeled after the defense program that helped develop the internet and GPS, just announced that three research teams have successfully regrown bone and cartilage — and in one case, an entire knee — in animal studies. Human trials are expected within 18 months.¹

My former colleague Dr. Scott Rodeo, vice chair of orthopedic research at the Hospital for Special Surgery where I completed my fellowship, called it "hugely promising" and a potential "paradigm shift." I don't use language like that lightly, but I agree with him.

Three teams, three very different strategies

What makes this exciting is that these aren't three variations on the same idea. Each team tackled the problem from a completely different angle:

Why this feels different

I've been in orthopedics long enough to have seen plenty of "breakthroughs" that didn't pan out. So why am I paying closer attention this time? A few reasons.

First, ARPA-H isn't a typical grant agency — these teams are contractually obligated to move from animal studies to human trials and, if successful, to commercialize the treatment. There's a built-in requirement that approved therapies cost no more than 25% of the current standard of care. That's a fundamentally different incentive structure than academic publishing.

Second, the Colorado team's results are striking: rabbits with the equivalent of an ACL-tear-induced arthritis saw full knee regeneration within two months of a single injection.¹ As someone who performs approximately 85 ACL surgeries a year, I know firsthand that post-traumatic arthritis is one of the biggest long-term concerns my patients face. An injection that could reverse that process would change how I counsel every ACL patient.

The honest caveats

Animal studies are not human studies. Rabbits and rats heal differently than we do, and plenty of therapies that look incredible in animals fail in clinical trials. The Columbia team's scaffold approach still needs large-animal testing. And even if human trials begin on schedule, we're likely years away from anything available in a clinic like mine.

I don't want anyone reading this to cancel their knee replacement consultation — if you're in pain now, the solutions we have today are excellent and well-proven.

I'll be following these trials closely. If you're dealing with knee arthritis and wondering what your options are — today or down the road — I'm always happy to talk it through in clinic.

This article is general education, not medical advice for your situation. Every knee and hip is different — talk with your own doctor about your care.